Effect of Anisotropic Electrical Conductivity Induced by Fiber Orientation on Ablation Characteristics of Pulsed Field Ablation in Atrial Fibrillation Treatment: A Computational Study
Abstract:Pulsed field ablation (PFA) is a promising new ablation modality for the treatment of atrial fibrillation (AF); however, the effect of fiber orientation on the ablation characteristics of PFA in AF treatment is still unclear, which is likely an essential factor in influencing the ablation characteristics. This study constructed an anatomy-based left atrium (LA) model incorporating fiber orientation and selected various electrical conductivity and ablation targets to investigate the effect of anisotropic electr… Show more
“…This implies a degree of anisotropy of only 11% in terms of electrical conductivity at low frequencies, which probably has a minimal impact on ablation modeling. Differences of around 26% were reported by Gabriel et al [25] at 40-70 Hz in three different directions, which implies an anisotropy ratio of 1.27, and much lower than those assumed by Zang et al [13] (between 1.43 and 6.25) in a computational PFA modeling study, who did find differences in terms of the lesion size induced by PFA between an isotropic and anisotropic model.…”
Even though the preliminary experimental data suggests that cardiac Pulsed Field Ablation (PFA) could be superior to radiofrequency ablation (RFA) in terms of being able to ablate the viable myocardium separated from the catheter by collagen and fat, as yet there is no formal physical-based analysis that describes the process by which fat can affect the electric field distribution. Our objective was thus to determine the electrical impact of intramyocardial fat during PFA by means of computer modeling. Computer models were built considering a PFA 3.5-mm blunt-tip catheter in contact with a 7-mm ventricular wall (with and without a scar) and a 2-mm epicardial fat layer. High voltage was set to obtain delivered currents of 19, 22 and 25 A. An electric field value of 1000 V/cm was considered as the lethal threshold. We found that the presence of fibrotic tissue in the scar seems to have a similar impact on the electric field distribution and lesion size to that of healthy myocardium only. However, intramyocardial fat considerably alters the electrical field distribution and the resulting lesion shape. The electric field tends to peak in zones with fat, even away from the ablation electrode, so that ‘cold points’ (i.e. low electric fields) appear around the fat at the current entry and exit points, while ‘hot points’ (high electric fields) occur in the lateral areas of the fat zones. The results show that intramyocardial fat can alter the electric field distribution and lesion size during PFA due to its much lower electrical conductivity than that of myocardium and fibrotic tissue.
“…This implies a degree of anisotropy of only 11% in terms of electrical conductivity at low frequencies, which probably has a minimal impact on ablation modeling. Differences of around 26% were reported by Gabriel et al [25] at 40-70 Hz in three different directions, which implies an anisotropy ratio of 1.27, and much lower than those assumed by Zang et al [13] (between 1.43 and 6.25) in a computational PFA modeling study, who did find differences in terms of the lesion size induced by PFA between an isotropic and anisotropic model.…”
Even though the preliminary experimental data suggests that cardiac Pulsed Field Ablation (PFA) could be superior to radiofrequency ablation (RFA) in terms of being able to ablate the viable myocardium separated from the catheter by collagen and fat, as yet there is no formal physical-based analysis that describes the process by which fat can affect the electric field distribution. Our objective was thus to determine the electrical impact of intramyocardial fat during PFA by means of computer modeling. Computer models were built considering a PFA 3.5-mm blunt-tip catheter in contact with a 7-mm ventricular wall (with and without a scar) and a 2-mm epicardial fat layer. High voltage was set to obtain delivered currents of 19, 22 and 25 A. An electric field value of 1000 V/cm was considered as the lethal threshold. We found that the presence of fibrotic tissue in the scar seems to have a similar impact on the electric field distribution and lesion size to that of healthy myocardium only. However, intramyocardial fat considerably alters the electrical field distribution and the resulting lesion shape. The electric field tends to peak in zones with fat, even away from the ablation electrode, so that ‘cold points’ (i.e. low electric fields) appear around the fat at the current entry and exit points, while ‘hot points’ (high electric fields) occur in the lateral areas of the fat zones. The results show that intramyocardial fat can alter the electric field distribution and lesion size during PFA due to its much lower electrical conductivity than that of myocardium and fibrotic tissue.
“…Physical field parameter simulation research is an important stage in the clinical application of new technologies, and reasonable PFA parameters will substantially reduce the cost of clinical research [ 37 , 44 , 74 ]. The researchers obtained a simplified cardiac model from between models of different complexities that can get more accurate simulation results, which provides data support for reducing the complexity of the model in the future.…”
Section: Discussion and Analysismentioning
confidence: 99%
“…The results showed that the difference in surface ablation area between anisotropic and isotropic conductivity was greater than 73.71%, and the percentage difference in ablation volume size was greater than 6.9%. It was shown that in left atrial ablation, anisotropic conductivity can be used for pulsed-field ablation if the same area and depth are considered [ 44 ]. PFA is classified as a non-thermal ablation technique, and the rise in tissue temperature is directly correlated with the heart’s blood flow.…”
Section: Pulsed Electric Field Ablation: Simulation Parameter Researchmentioning
In recent years, the prevalence of and mortality associated with cardiovascular diseases have been rising in most countries and regions. AF is the most common arrhythmic condition, and there are several treatment options for AF. Pulmonary vein isolation is an effective treatment for AF and is the cornerstone of current ablation techniques, which have one major limitation: even when diagnosed and treated at a facility that specializes in ablation, patients have a greater chance of recurrence. Therefore, there is a need to develop better ablation techniques for the treatment of AF. This article first compares the current cryoablation (CBA) and radiofrequency ablation (RFA) techniques for the treatment of AF and discusses the utility and advantages of the development of pulsed-field ablation (PFA) technology. The current research on PFA is summarized from three perspectives, namely, simulation experiments, animal experiments, and clinical studies. The results of different stages of experiments are summarized, especially during animal studies, where pulmonary vein isolation was carried out effectively without causing injury to the phrenic nerve, esophagus, and pulmonary veins, with higher safety and shorter incision times. This paper focuses on a review of various a priori and clinical studies of this new technique for the treatment of AF.
“…Another increasingly important application of electroporation in biomedicine is treatment of cardiac arrhythmias, particularly of atrial fibrillation, by ablation of pulmonary vein tissue using irreversible electroporation [10], [15]- [18]. The specific structure of skeletal and cardiac muscles dictates an anisotropic electrical conductivity, leading to a fibre-orientation dependent electric field distribution upon pulse application [19]- [21]. The electrical conductivity of skeletal muscle in the direction of its fibres was found to be higher than the electrical conductivity in the direction perpendicular to the fibres [22]- [27].…”
The goal of our study was to determine the importance of electric field orientation in an anisotropic muscle tissue for the extent of irreversible electroporation damage by means of an experimentally validated mathematical model. Methods: Electrical pulses were delivered to porcine skeletal muscle in vivo by inserting needle electrodes so that the electric field was applied in direction either parallel or perpendicular to the direction of the muscle fibres. Triphenyl tetrazolium chloride staining was used to determine the shape of the lesions. Next, we used a single cell model to determine the cell-level conductivity during electroporation, and then generalised the calculated conductivity changes to the bulk tissue. Finally, we compared the experimental lesions with the calculated field strength distributions using the Sørensen-Dice similarity coefficient to find the contours of the electric field strength threshold beyond which irreversible damage is thought to occur. Results: Lesions in the parallel group were consistently smaller and narrower than lesions in the perpendicular group. The determined irreversible threshold of electroporation for the selected pulse protocol was 193.4 V/cm with a standard deviation of 42.1 V/cm, and was not dependent on field orientation. Conclusion: Muscle anisotropy is of significant importance when considering electric field distribution in electroporation applications. Significance: The paper presents an important advancement in building up from the current understanding of single cell electroporation to an in silico multiscale model of bulk muscle tissue. The model accounts for anisotropic electrical conductivity and has been validated through experiments in vivo.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.